)

Hologic (HOLX) investor relations material
Hologic Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Business performance and challenges
Breast health business faced deeper-than-expected softness in the first half, but returned to growth in the fourth quarter after organizational changes and improved execution.
Diagnostics business remains a strong growth engine, with high single-digit revenue growth and increased Panther platform utilization.
HIV testing in Africa was impacted by international aid cuts, but overall business resilience and adaptability have strengthened the foundation for future growth.
Surgical business saw MyoSure continue to grow, while NovaSure faced long-term decline due to alternative treatments.
Operating margins are expected to remain around 30% despite tariff headwinds, with a focus on maintaining strong financial health.
Innovation and product development
Panther platform expansion with Fusion add-on increases menu and PCR capabilities, providing five years of growth runway.
BVCV assay is a major growth driver, with strong competitive positioning in the U.S. and potential for market expansion internationally.
Envision mammography platform launch expected next year, offering improved imaging, faster scans, and enhanced patient and technician experience.
Digital cytology and AI integration are improving workflow and expanding opportunities, especially outside the U.S.
Endomag and Gynesonics acquisitions are performing well, broadening the surgical portfolio and supporting growth.
Market trends and strategic outlook
Diagnostics market is expected to grow with continued decentralization and adoption of Panther in international markets.
International breast health market remains underdeveloped, with significant runway for 3D mammography adoption and policy-driven growth.
Self-collection in diagnostics is seen as more additive than disruptive, with current limitations in science, economics, and patient behavior.
Capital allocation prioritizes acquisitions to accelerate top-line growth, while maintaining buybacks and a strong balance sheet.
Execution improvements and market development are expected to drive growth across all business segments next year.
Next Hologic earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage